These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2498960)

  • 1. Differential mechanisms in the acquisition and expression of heroin-induced place preference.
    Hand TH; Stinus L; Le Moal M
    Psychopharmacology (Berl); 1989; 98(1):61-7. PubMed ID: 2498960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone enhances the expression of morphine-induced conditioned place preference.
    Neisewander JL; Pierce RC; Bardo MT
    Psychopharmacology (Berl); 1990; 100(2):201-5. PubMed ID: 2305008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat.
    Tzschentke TM; Magalas Z; De Vry J
    Addict Biol; 2006 Mar; 11(1):64-71. PubMed ID: 16759338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats.
    Yusoff NHM; Mansor SM; Müller CP; Hassan Z
    Behav Brain Res; 2017 Aug; 332():1-6. PubMed ID: 28559179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rewarding properties of beta-endorphin as measured by conditioned place preference.
    Amalric M; Cline EJ; Martinez JL; Bloom FE; Koob GF
    Psychopharmacology (Berl); 1987; 91(1):14-9. PubMed ID: 2950541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reacquisition of heroin and cocaine place preference involves a memory consolidation process sensitive to systemic and intra-ventral tegmental area naloxone.
    Sticht M; Mitsubata J; Tucci M; Leri F
    Neurobiol Learn Mem; 2010 Feb; 93(2):248-60. PubMed ID: 19857583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone effects on extinction of ethanol- and cocaine-induced conditioned place preference in mice.
    Font L; Houck CA; Cunningham CL
    Psychopharmacology (Berl); 2017 Sep; 234(18):2747-2759. PubMed ID: 28653079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats.
    Rutten K; Van Der Kam EL; De Vry J; Bruckmann W; Tzschentke TM
    Addict Biol; 2011 Jan; 16(1):108-15. PubMed ID: 20579001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate reinforcement and naloxone aversion, as revealed by place preference paradigm, in two strains of rats.
    Dymshitz J; Lieblich I
    Psychopharmacology (Berl); 1987; 92(4):473-7. PubMed ID: 3114801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noni (Morinda citrifolia L.) fruit extract attenuates the rewarding effect of heroin in conditioned place preference but not withdrawal in rodents.
    Narasingam M; Pandy V; Mohamed Z
    Exp Anim; 2016 May; 65(2):157-64. PubMed ID: 26744024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic flupentixol treatment potentiates the reinforcing properties of systemic heroin administration.
    Stinus L; Nadaud D; Deminière JM; Jauregui J; Hand TT; Le Moal M
    Biol Psychiatry; 1989 Aug; 26(4):363-71. PubMed ID: 2765599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
    Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
    Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone blockade of amphetamine place preference conditioning.
    Trujillo KA; Belluzzi JD; Stein L
    Psychopharmacology (Berl); 1991; 104(2):265-74. PubMed ID: 1876671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat.
    van der Kam EL; De Vry J; Tzschentke TM
    Eur J Pharmacol; 2009 Mar; 606(1-3):94-101. PubMed ID: 19210976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide.
    Neisewander JL; Bardo MT
    Psychopharmacology (Berl); 1987; 93(3):314-9. PubMed ID: 2829265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats.
    Schulteis G; Stinus L; Risbrough VB; Koob GF
    Neuropsychopharmacology; 1998 Nov; 19(5):406-16. PubMed ID: 9778662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inactivating the agranular or granular insular cortex on the acquisition of the morphine-induced conditioned place preference and naloxone-precipitated conditioned place aversion in rats.
    Li CL; Zhu N; Meng XL; Li YH; Sui N
    J Psychopharmacol; 2013 Sep; 27(9):837-44. PubMed ID: 23784741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
    Braida D; Pozzi M; Cavallini R; Sala M
    Neuroscience; 2001; 104(4):923-6. PubMed ID: 11457579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical substrates for opiate reinforcement.
    Koob GF; Vaccarino FJ; Amalric M; Bloom FE
    NIDA Res Monogr; 1986; 71():146-64. PubMed ID: 3025733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.